Figure 2From: In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin Dose-response relationship of innovator oxacillin (OXA-BMS) in 4 independent experiments in the neutropenic mouse thigh infection model, fitted to Hill's model by NLR. The four experiments (gray lines) were indistinguishable by curve fitting analysis (CFA), thus a single regression (red curve) described them better than 4 individual regressions.Back to article page